A Novel Anti-B7-H3 × Anti-CD3 Bispecific Antibody with Potent Antitumor Activity.

Feng, Yan; Xie, Kun; Yin, Yanxin; Li, Bingyu; Pi, Chenyu; Xu, Xiaoqing; Huang, Tao; Zhang, Jingming; Wang, Bo; Gu, Hua; Fang, Jianmin

Feng, Yan; Xie, Kun; Yin, Yanxin; Li, Bingyu; Pi, Chenyu; Xu, Xiaoqing; Huang, Tao; Zhang, Jingming; Wang, Bo; Gu, Hua; Fang, Jianmin.

Afiliación

Feng Y; School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
Xie K; School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
Yin Y; School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
Li B; Biomedical Research Center, Suzhou 230031, China.
Pi C; School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
Xu X; School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
Huang T; School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
Zhang J; School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
Wang B; School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
Gu H; School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
Fang J; School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.

Life (Basel) ; 12(2)2022 Jan 21.

Article en En | MEDLINE | ID: mdl-35207448

Palabras clave

B7-H3; bispecific T cell engager; immunotherapy; solid tumor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Life (Basel) Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google